s6y
Company name or ticker
Search
Cellectar Biosciences, Inc.
4
CARUSO JAMES V: Statement of changes in beneficial ownership of securities
Filed
Thursday, January 27, 2022
Period
Jan 25, 2022
Accession number
0001104659-22-008277
Documents
OWNERSHIP DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header